Clinical Assessment of Histidine-Tryptophan-Ketoglutarate Solution and Modified St. Thomas' Solution in Pediatric Cardiac Surgery of Tetralogy of Fallot
Autor: | Ming-Cheng Du, Yong An, Ting-Jiang Qin, Hong-Zhen Xu, Li-Qun Yang, Zhao-Hui Wang, Yin-Bei Liu |
---|---|
Rok vydání: | 2016 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment Biomedical Engineering Medicine (miscellaneous) Bioengineering 030204 cardiovascular system & hematology law.invention Biomaterials 03 medical and health sciences 0302 clinical medicine law medicine.artery medicine Tetralogy of Fallot Mechanical ventilation Aorta Histidine-tryptophan-ketoglutarate solution business.industry General Medicine Perioperative medicine.disease Intensive care unit Cardiac surgery Surgery 030228 respiratory system Anesthesia Thomas' solution business |
Zdroj: | Artificial Organs. 41:470-475 |
ISSN: | 0160-564X |
Popis: | The objective of this study is to compare the myocardium protective effect of Bretschneider's histidine-tryptophan-ketoglutarate (HTK) solution versus Modified St. Thomas' (STH) solution in pediatric cardiac surgery of Tetralogy of Fallot (TOF). Seventy-seven pediatric patients of TOF who received the total surgical repair were reviewed, from January 2014 to October 2015. A horizontal comparison between HTK solution and modified STH solution has been made since the HTK solutions were started to be used in our hospital. The patients were divided into the HTK group (n = 35) and the STH group (n = 33). The perioperative values of the groups were assessed in this study. The primary endpoints including spontaneous cardiac re-beating time, intensive care unit (ICU) stay, overall stay, mechanical ventilation postoperation, postoperation stay, overall stay, and perioperative echocardiographic results were analyzed in this study. We found that spontaneous cardiac re-beating time of the HTK group was significantly shorter than that of the STH group (0.26 min ± 0.56 vs. 1.33 ± 1.02, P |
Databáze: | OpenAIRE |
Externí odkaz: |